Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1196713-21-9

Post Buying Request

1196713-21-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1196713-21-9 Usage

Uses

4-(Piperidin-3-yl)aniline is a reagent used in the large-scale synthesis of an oral PARP inhibitor.

Check Digit Verification of cas no

The CAS Registry Mumber 1196713-21-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,6,7,1 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1196713-21:
(9*1)+(8*1)+(7*9)+(6*6)+(5*7)+(4*1)+(3*3)+(2*2)+(1*1)=169
169 % 10 = 9
So 1196713-21-9 is a valid CAS Registry Number.

1196713-21-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(3S)-piperidin-3-yl]aniline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1196713-21-9 SDS

1196713-21-9Relevant articles and documents

Preparation method of intermediate for synthesizing antitumor medicine niraparib and intermediate

-

, (2019/02/17)

The invention discloses a preparation method of an intermediate for synthesizing an antitumor medicine niraparib and the intermediate. The invention discloses a preparation method of a compound f, which comprises the following step: in a solvent, under the effect of alkali, performing ring-closure reaction as a formula shown below on a compound e to obtain the compound f. The preparation method does not relate to the steps of noble metal catalytic reduction or noble metal catalytic coupling and chiral resolution; the requirement on the equipment is low; the operation is simple; the industrialproduction is facilitated; the generation of heavy metal-containing and phosphorous waste liquid can be avoided; the cost is low; the product ee value is high. The formula is shown in the description.

Synthesis method for (R)-3-phenylpiperidine or/and (S)-3-phenylpiperidine and synthesis method for chiral intermediate of niraparib

-

, (2018/07/10)

The invention belongs to the technical field of organic synthesis. The synthesis method firstly provided by the invention takes benzyl-4-oxopiperidine as a starting material, and the starting materialis subjected to Grignard reaction, elimination reaction, hydrogenation reduction reaction and chiral resolution in sequence to successfully obtain a target product (R)-3-phenylpiperidine or/ and (S)-3-phenylpiperidine. The synthesis method sencondly provided by the invention takes the same starting raw material for Grignard reaction, organic silicon reagent is used for removing a hydroxide radical, and benzyl is removed by catalytic hydrogenation reaction; finally, the chiral resolution is carried out to obtain a target product. The (S)-3-phenylpiperidine can be synthesized according to the synthesis method. (S)-3-p-aminosalicylic phenylpiperidine can be synthesized according to the third aspect; or according to the fourth aspect, (S)-3-p-bromophenyl piperidine is synthesized to serve asthe key intermediate for preparing the niraparib. According to the synthesis method for (R)-3-phenylpiperidine or/ and (S)-3-phenylpiperidine and the synthesis method for chiral intermediate of niraparib, production cost is obviously lowered, and the synthesis methods are favorable for the large-scale industrial production of a niraparib medicine.

A prepares Nepal to pull handkerchief Nepal method (by machine translation)

-

Paragraph 0051; 0052, (2017/07/23)

The invention discloses a compound 2 - [4 - ((3S) - 3 - piperidinyl) phenyl] - 2H - indazole - 7 - carboxamide preparation method, through the 4 - nitro phenylpyridyl with reaction produced animal pen halogenphenmethyl season ammonium salt, by sodium borohydride reduction of the pyridine quaternary ammonium salt, in the palladium reagent obtained under the action of the 3 - (4 - aminophenyl) piperidine, in the chiral reagent obtained under the action of the (S)- 3 - (4 - halophenyl) piperidine, with 3 - formyl - 2 - nitro-benzoic acid methyl ester condensation and in sodium azide formed under the action of powder medicine, after preparing the amine Niraparib (molecular entity is: 2 - [4 - ((3S) - 3 - piperidinyl) phenyl] - 2H - indazole - 7 - carboxamide). (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1196713-21-9